Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Oncodox-O 50mg


Contraindicated
Absolute contraindication

Contraindicated
Absolute contraindication
Oncodox-O 50mg :
Type Medicine Non Marketed
Originator Adriblastina 50mg*
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory Cipla
Responsible Party Cipla Ltd
Origin India
Manufacturer Cipla Ltd
Manufacturing Type G
Origin India
ATC L01DB01

Your comment will appear shortly after approval

Oncodox-O 50mg :

Revision Date : 01/10/2015


Effect Frequency
Abdominal pain Common
Abnormal ECG Very Common
Acute lymphocytic leukaemia (Acute lymphoblastic leukemia) Not known
Acute myeloid leukaemia Not known
Administration site reaction Common
Alopecia Very Common
Amenorrhoea (amenorrhea) Not known
Anaemia Very Common
Anaphylactic reactions Not known
Anorexia Very Common
Asthenia Very Common
Atrioventricular block (AVB) Not known
Azoospermia Not known
Bundle branch block Not known
Chills Very Common
Colitis Not known
Congestive heart failure Common
Conjunctivitis Common
Dehydration Not known
Diarrhoea (Diarrhea) Very Common
Ejection fraction decreased Very Common
Eruption Common
Fever Very Common
Gastric erosions Not known
Gastroduodenal haemorrhage Not known
Haemorrhage Not known
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Very Common
Hot flush Not known
Hyperuricaemia Not known
Infection Very Common
Keratitis Not known
Lacrimation increased (Epiphora) Not known
Leucopenia (Leukopenia) Very Common
Malaise Not known
Mucositis Very Common
Nausea Very Common
Neutropenia Very Common
Oesophagitis Common
Oligospermia Not known
Phlebitis Not known
Photosensitivity reaction Not known
Pruritus Not known
Radiation recall reaction (dermatologic) Not known
Septicemia Common
Shock Not known
Sinus tachycardia Common
Skin hyperpigmentation Common
Stomatitis Very Common
Tachyarrhythmia Not known
Thrombocytopenia (Thrombopenia) Very Common
Thromboembolism Uncommon
Thrombophlebitis Not known
Transaminases abnormal Very Common
Urine coloring red Not known
Urticaria Common
Vomiting Very Common
Weight increased (weight gain) Very Common

Different Units By MoH Code

Revision Date : 01/03/2017

Oncodox-O 50mg Oncodox-O 50mg Oncodox-O 50mg Oncodox-O 50mg Oncodox-O 50mg Oncodox-O 50mg Oncodox-O 50mg

Oncodox-O 50mg  MoH 7053 :
Form Powder for solution for injection
Packaging Vial + Ampoule
Package Size Box of 1
Strength 50mg
Storage Condition <25°C Away from moisture
NSSF ✘
Quarantine ✘
Reg. Number 219573/09
Submission date 01/01/2009
Registration Year 2013
Archived Date 03/05/2023


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info